✦ LIBER ✦

ABX-EGF, a fully human anti-epidermal growth factor receptor (EGFr) monoclonal antibody: phase II clinical trial in renal cell cancer (RCC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic potential of ABX-EGF: A full

✍ David H Lynch; Xiao-Dong Yang 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Randomized Phase III Trial Results of Pa

✍ Tara Beers Gibson; Aarati Ranganathan; Axel Grothey 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 124 KB

Phase II study of nimotuzumab, a humaniz

✍ Dirk Strumberg, Beate Schultheis, M. E. Scheulen, R. A. Hilger, J. Krauss, N. Ma 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 144 KB

Results of a phase I trial of the humani

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB

732 POSTER Phase I clinical study of the

✍ J. Soriano; N. Batista; M. Lima; R. Rodríguez; M.V. López; A. Montenegro; M. Ram 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 83 KB

55 Randomized phase II clinical trial of

✍ R. Rosell; R. Ramlau; A. Szczesna; C. Daniel; M. Bertrand; R. Garcia-Arroyo; K. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB